Profile picture

Doctor Eli Roth

University of Cincinnati, Cincinnati (United States of America)
Follow
Logo ESC

Contributor content

Assessment of absolute reductions in LDL-C associated with alirocumab therapy: results from across the Phase 3 ODYSSEY programme
Presentation
Assessment of absolute reductions in LDL-C associated with alirocumab therapy: results from across the Phase 3 ODYSSEY programme
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources